nodes	percent_of_prediction	percent_of_DWPC	metapath
Vemurafenib—melanoma—ocular cancer	0.372	0.518	CtDrD
Vemurafenib—skin cancer—ocular cancer	0.346	0.482	CtDrD
Vemurafenib—ABCC1—Dactinomycin—ocular cancer	0.107	0.472	CbGbCtD
Vemurafenib—ABCG2—Dactinomycin—ocular cancer	0.0716	0.316	CbGbCtD
Vemurafenib—ABCG2—Carboplatin—ocular cancer	0.0481	0.212	CbGbCtD
Vemurafenib—BRAF—Signaling by NGF—CDKN1A—ocular cancer	3.8e-05	0.000683	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR in Cancer—CDKN1A—ocular cancer	3.79e-05	0.000682	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by PDGF—CDKN1A—ocular cancer	3.78e-05	0.000679	CbGpPWpGaD
Vemurafenib—RAF1—Focal Adhesion—CCND1—ocular cancer	3.77e-05	0.000678	CbGpPWpGaD
Vemurafenib—RAF1—VEGFA-VEGFR2 Pathway—HRAS—ocular cancer	3.76e-05	0.000676	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	3.75e-05	0.000675	CbGpPWpGaD
Vemurafenib—RAF1—Corticotropin-releasing hormone—AKT1—ocular cancer	3.75e-05	0.000674	CbGpPWpGaD
Vemurafenib—RAF1—TNF alpha Signaling Pathway—AKT1—ocular cancer	3.75e-05	0.000674	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by Interleukins—HRAS—ocular cancer	3.73e-05	0.000671	CbGpPWpGaD
Vemurafenib—RAF1—NGF signalling via TRKA from the plasma membrane—CDKN1B—ocular cancer	3.71e-05	0.000666	CbGpPWpGaD
Vemurafenib—BRAF—Integrated Breast Cancer Pathway—AKT1—ocular cancer	3.64e-05	0.000655	CbGpPWpGaD
Vemurafenib—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—ocular cancer	3.64e-05	0.000654	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by FGFR in disease—HRAS—ocular cancer	3.63e-05	0.000653	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	3.63e-05	0.000653	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—E2F3—ocular cancer	3.61e-05	0.000649	CbGpPWpGaD
Vemurafenib—RAF1—B Cell Receptor Signaling Pathway—AKT1—ocular cancer	3.59e-05	0.000646	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by VEGF—HRAS—ocular cancer	3.55e-05	0.000638	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ocular cancer	3.54e-05	0.000637	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ocular cancer	3.53e-05	0.000635	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by Insulin receptor—HRAS—ocular cancer	3.53e-05	0.000634	CbGpPWpGaD
Vemurafenib—RAF1—Integrin-mediated Cell Adhesion—AKT1—ocular cancer	3.51e-05	0.00063	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	3.46e-05	0.000621	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by FGFR—AKT1—ocular cancer	3.44e-05	0.000619	CbGpPWpGaD
Vemurafenib—BRAF—EGF/EGFR Signaling Pathway—AKT1—ocular cancer	3.44e-05	0.000619	CbGpPWpGaD
Vemurafenib—BRAF—Focal Adhesion—HRAS—ocular cancer	3.43e-05	0.000617	CbGpPWpGaD
Vemurafenib—RAF1—NGF signalling via TRKA from the plasma membrane—CDKN1A—ocular cancer	3.42e-05	0.000615	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—SAG—ocular cancer	3.39e-05	0.000609	CbGpPWpGaD
Vemurafenib—RAF1—ErbB1 downstream signaling—AKT1—ocular cancer	3.37e-05	0.000606	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—TFDP1—ocular cancer	3.35e-05	0.000603	CbGpPWpGaD
Vemurafenib—BRAF—MAPK Signaling Pathway—AKT1—ocular cancer	3.35e-05	0.000601	CbGpPWpGaD
Vemurafenib—RAF1—MAPK Signaling Pathway—MYC—ocular cancer	3.34e-05	0.0006	CbGpPWpGaD
Vemurafenib—RAF1—MAPK Signaling Pathway—TGFB1—ocular cancer	3.33e-05	0.000599	CbGpPWpGaD
Vemurafenib—RAF1—TGF-beta Signaling Pathway—TP53—ocular cancer	3.32e-05	0.000598	CbGpPWpGaD
Vemurafenib—RAF1—PDGFR-beta signaling pathway—HRAS—ocular cancer	3.32e-05	0.000597	CbGpPWpGaD
Vemurafenib—RAF1—VEGFA-VEGFR2 Pathway—AKT1—ocular cancer	3.32e-05	0.000597	CbGpPWpGaD
Vemurafenib—RAF1—Disease—TFDP1—ocular cancer	3.31e-05	0.000596	CbGpPWpGaD
Vemurafenib—BRAF—Transmission across Chemical Synapses—HRAS—ocular cancer	3.3e-05	0.000592	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PSPH—ocular cancer	3.29e-05	0.000592	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—TFDP1—ocular cancer	3.29e-05	0.000591	CbGpPWpGaD
Vemurafenib—ALB—Platelet degranulation—TGFB1—ocular cancer	3.24e-05	0.000583	CbGpPWpGaD
Vemurafenib—BRAF—NGF signalling via TRKA from the plasma membrane—HRAS—ocular cancer	3.22e-05	0.000579	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by FGFR in disease—AKT1—ocular cancer	3.21e-05	0.000577	CbGpPWpGaD
Vemurafenib—RAF1—Neuronal System—MDM2—ocular cancer	3.18e-05	0.000572	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by VEGF—AKT1—ocular cancer	3.13e-05	0.000563	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—MDM2—ocular cancer	3.12e-05	0.000561	CbGpPWpGaD
Vemurafenib—ALB—Folate Metabolism—TP53—ocular cancer	3.12e-05	0.00056	CbGpPWpGaD
Vemurafenib—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—ocular cancer	3.09e-05	0.000556	CbGpPWpGaD
Vemurafenib—RAF1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ocular cancer	3.03e-05	0.000545	CbGpPWpGaD
Vemurafenib—BRAF—Focal Adhesion—AKT1—ocular cancer	3.03e-05	0.000545	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by SCF-KIT—HRAS—ocular cancer	3.02e-05	0.000542	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	3.01e-05	0.000541	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	3e-05	0.00054	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—E2F5—ocular cancer	3e-05	0.000539	CbGpPWpGaD
Vemurafenib—RAF1—BDNF signaling pathway—HRAS—ocular cancer	2.97e-05	0.000533	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—E2F4—ocular cancer	2.94e-05	0.000528	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signaling of activated FGFR—HRAS—ocular cancer	2.89e-05	0.000519	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—RBL1—ocular cancer	2.88e-05	0.000518	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—CDKN1B—ocular cancer	2.85e-05	0.000512	CbGpPWpGaD
Vemurafenib—BRAF—NGF signalling via TRKA from the plasma membrane—AKT1—ocular cancer	2.84e-05	0.000511	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB4—HRAS—ocular cancer	2.84e-05	0.00051	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—CDK2—ocular cancer	2.82e-05	0.000507	CbGpPWpGaD
Vemurafenib—RAF1—TGF-beta Signaling Pathway—AKT1—ocular cancer	2.81e-05	0.000505	CbGpPWpGaD
Vemurafenib—BRAF—Disease—HDAC1—ocular cancer	2.78e-05	0.0005	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	2.78e-05	0.0005	CbGpPWpGaD
Vemurafenib—RAF1—MAPK Signaling Pathway—TP53—ocular cancer	2.74e-05	0.000493	CbGpPWpGaD
Vemurafenib—RAF1—Insulin Signaling—HRAS—ocular cancer	2.73e-05	0.00049	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—GNA11—ocular cancer	2.72e-05	0.00049	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—CDK4—ocular cancer	2.72e-05	0.000489	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PSPH—ocular cancer	2.72e-05	0.000488	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signal transduction—HRAS—ocular cancer	2.71e-05	0.000488	CbGpPWpGaD
Vemurafenib—RAF1—EGF/EGFR Signaling Pathway—HRAS—ocular cancer	2.7e-05	0.000485	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR—HRAS—ocular cancer	2.7e-05	0.000485	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB2—HRAS—ocular cancer	2.69e-05	0.000483	CbGpPWpGaD
Vemurafenib—RAF1—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	2.67e-05	0.000481	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 signaling—HRAS—ocular cancer	2.67e-05	0.00048	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—MAML2—ocular cancer	2.66e-05	0.000479	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by SCF-KIT—AKT1—ocular cancer	2.66e-05	0.000479	CbGpPWpGaD
Vemurafenib—RAF1—Disease—MAML2—ocular cancer	2.63e-05	0.000473	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—CDKN1A—ocular cancer	2.63e-05	0.000473	CbGpPWpGaD
Vemurafenib—RAF1—BDNF signaling pathway—AKT1—ocular cancer	2.62e-05	0.000471	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—MAML2—ocular cancer	2.61e-05	0.000469	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—GNA11—ocular cancer	2.55e-05	0.000459	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signaling of activated FGFR—AKT1—ocular cancer	2.55e-05	0.000458	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—GNAQ—ocular cancer	2.53e-05	0.000455	CbGpPWpGaD
Vemurafenib—BRAF—Neuronal System—HRAS—ocular cancer	2.52e-05	0.000454	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR in disease—HRAS—ocular cancer	2.51e-05	0.000452	CbGpPWpGaD
Vemurafenib—RAF1—Fc epsilon receptor (FCERI) signaling—HRAS—ocular cancer	2.51e-05	0.000452	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 interactions—HRAS—ocular cancer	2.51e-05	0.000452	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB4—AKT1—ocular cancer	2.51e-05	0.000451	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—E2F3—ocular cancer	2.5e-05	0.000449	CbGpPWpGaD
Vemurafenib—BRAF—Disease—CDKN2B—ocular cancer	2.49e-05	0.000448	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR—HRAS—ocular cancer	2.49e-05	0.000448	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by NGF—HRAS—ocular cancer	2.48e-05	0.000445	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	2.47e-05	0.000445	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR in Cancer—HRAS—ocular cancer	2.47e-05	0.000444	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by PDGF—HRAS—ocular cancer	2.46e-05	0.000442	CbGpPWpGaD
Vemurafenib—RAF1—Insulin Signaling—AKT1—ocular cancer	2.41e-05	0.000433	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signal transduction—AKT1—ocular cancer	2.39e-05	0.00043	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR—AKT1—ocular cancer	2.38e-05	0.000428	CbGpPWpGaD
Vemurafenib—RAF1—EGF/EGFR Signaling Pathway—AKT1—ocular cancer	2.38e-05	0.000428	CbGpPWpGaD
Vemurafenib—RAF1—Focal Adhesion—HRAS—ocular cancer	2.38e-05	0.000427	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—GNAQ—ocular cancer	2.37e-05	0.000427	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB2—AKT1—ocular cancer	2.37e-05	0.000426	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 signaling—AKT1—ocular cancer	2.36e-05	0.000424	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—GNA11—ocular cancer	2.33e-05	0.000418	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—TFDP1—ocular cancer	2.32e-05	0.000417	CbGpPWpGaD
Vemurafenib—RAF1—MAPK Signaling Pathway—AKT1—ocular cancer	2.31e-05	0.000416	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PSPH—ocular cancer	2.3e-05	0.000414	CbGpPWpGaD
Vemurafenib—RAF1—Transmission across Chemical Synapses—HRAS—ocular cancer	2.28e-05	0.00041	CbGpPWpGaD
Vemurafenib—RAF1—NGF signalling via TRKA from the plasma membrane—HRAS—ocular cancer	2.23e-05	0.0004	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 interactions—AKT1—ocular cancer	2.22e-05	0.000399	CbGpPWpGaD
Vemurafenib—RAF1—Fc epsilon receptor (FCERI) signaling—AKT1—ocular cancer	2.22e-05	0.000399	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR in disease—AKT1—ocular cancer	2.22e-05	0.000399	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR—AKT1—ocular cancer	2.2e-05	0.000395	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by NGF—AKT1—ocular cancer	2.19e-05	0.000393	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR in Cancer—AKT1—ocular cancer	2.18e-05	0.000392	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by PDGF—AKT1—ocular cancer	2.17e-05	0.00039	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—GNAQ—ocular cancer	2.16e-05	0.000389	CbGpPWpGaD
Vemurafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ocular cancer	2.15e-05	0.000387	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—HDAC1—ocular cancer	2.14e-05	0.000385	CbGpPWpGaD
Vemurafenib—RAF1—Focal Adhesion—AKT1—ocular cancer	2.1e-05	0.000377	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	2.09e-05	0.000375	CbGpPWpGaD
Vemurafenib—RAF1—NGF signalling via TRKA from the plasma membrane—AKT1—ocular cancer	1.97e-05	0.000353	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—HDAC1—ocular cancer	1.95e-05	0.00035	CbGpPWpGaD
Vemurafenib—RAF1—Disease—HDAC1—ocular cancer	1.93e-05	0.000346	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—HDAC1—ocular cancer	1.91e-05	0.000343	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—GNA11—ocular cancer	1.91e-05	0.000343	CbGpPWpGaD
Vemurafenib—RAF1—Platelet activation, signaling and aggregation—AKT1—ocular cancer	1.86e-05	0.000334	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—MAML2—ocular cancer	1.84e-05	0.000331	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—MDM2—ocular cancer	1.78e-05	0.00032	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PSPH—ocular cancer	1.78e-05	0.000319	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—GNAQ—ocular cancer	1.77e-05	0.000319	CbGpPWpGaD
Vemurafenib—RAF1—Neuronal System—HRAS—ocular cancer	1.75e-05	0.000314	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CDKN2B—ocular cancer	1.75e-05	0.000314	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—HRAS—ocular cancer	1.74e-05	0.000313	CbGpPWpGaD
Vemurafenib—RAF1—Disease—CDKN2B—ocular cancer	1.73e-05	0.00031	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—HRAS—ocular cancer	1.71e-05	0.000308	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—CDKN2B—ocular cancer	1.71e-05	0.000308	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—MDM2—ocular cancer	1.71e-05	0.000307	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—GNA11—ocular cancer	1.68e-05	0.000302	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—CDKN1B—ocular cancer	1.63e-05	0.000292	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—EP300—ocular cancer	1.62e-05	0.000291	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—GNA11—ocular cancer	1.61e-05	0.000289	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—E2F1—ocular cancer	1.6e-05	0.000288	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—EP300—ocular cancer	1.59e-05	0.000285	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—CDKN1B—ocular cancer	1.56e-05	0.000281	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—GNAQ—ocular cancer	1.56e-05	0.00028	CbGpPWpGaD
Vemurafenib—RAF1—Axon guidance—HRAS—ocular cancer	1.55e-05	0.000279	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—CDK2—ocular cancer	1.52e-05	0.000273	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—AKT1—ocular cancer	1.51e-05	0.000272	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—CDKN1A—ocular cancer	1.5e-05	0.00027	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—GNAQ—ocular cancer	1.5e-05	0.000269	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—CDKN1A—ocular cancer	1.44e-05	0.000259	CbGpPWpGaD
Vemurafenib—ALB—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	1.44e-05	0.000259	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	1.43e-05	0.000257	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—EP300—ocular cancer	1.43e-05	0.000257	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—TGFB1—ocular cancer	1.4e-05	0.000253	CbGpPWpGaD
Vemurafenib—BRAF—Disease—MDM2—ocular cancer	1.38e-05	0.000249	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—TGFB1—ocular cancer	1.38e-05	0.000248	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—HDAC1—ocular cancer	1.35e-05	0.000242	CbGpPWpGaD
Vemurafenib—BRAF—Disease—CDKN1B—ocular cancer	1.26e-05	0.000227	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CDKN2B—ocular cancer	1.21e-05	0.000217	CbGpPWpGaD
Vemurafenib—BRAF—Disease—CDKN1A—ocular cancer	1.17e-05	0.00021	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—TP53—ocular cancer	1.13e-05	0.000204	CbGpPWpGaD
Vemurafenib—BRAF—Disease—EP300—ocular cancer	1.11e-05	0.000199	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—E2F1—ocular cancer	1.11e-05	0.000199	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—HRAS—ocular cancer	1.11e-05	0.000199	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—HRAS—ocular cancer	1.09e-05	0.000195	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—MDM2—ocular cancer	1.04e-05	0.000186	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—GNA11—ocular cancer	1.04e-05	0.000186	CbGpPWpGaD
Vemurafenib—ALB—Platelet activation, signaling and aggregation—AKT1—ocular cancer	1e-05	0.00018	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—HRAS—ocular cancer	9.77e-06	0.000176	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—AKT1—ocular cancer	9.77e-06	0.000176	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—MDM2—ocular cancer	9.69e-06	0.000174	CbGpPWpGaD
Vemurafenib—BRAF—Disease—MYC—ocular cancer	9.67e-06	0.000174	CbGpPWpGaD
Vemurafenib—BRAF—Disease—TGFB1—ocular cancer	9.64e-06	0.000173	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—GNAQ—ocular cancer	9.63e-06	0.000173	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—AKT1—ocular cancer	9.58e-06	0.000172	CbGpPWpGaD
Vemurafenib—RAF1—Disease—MDM2—ocular cancer	9.57e-06	0.000172	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—MDM2—ocular cancer	9.49e-06	0.000171	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CDKN1B—ocular cancer	9.47e-06	0.00017	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—HRAS—ocular cancer	9.38e-06	0.000169	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CDKN1B—ocular cancer	8.85e-06	0.000159	CbGpPWpGaD
Vemurafenib—RAF1—Disease—CDKN1B—ocular cancer	8.74e-06	0.000157	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CDKN1A—ocular cancer	8.74e-06	0.000157	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—CDKN1B—ocular cancer	8.66e-06	0.000156	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—AKT1—ocular cancer	8.63e-06	0.000155	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GNA11—ocular cancer	8.55e-06	0.000154	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—EP300—ocular cancer	8.53e-06	0.000153	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CCND1—ocular cancer	8.44e-06	0.000152	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—EP300—ocular cancer	8.31e-06	0.000149	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—AKT1—ocular cancer	8.28e-06	0.000149	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CDKN1A—ocular cancer	8.16e-06	0.000147	CbGpPWpGaD
Vemurafenib—RAF1—Disease—CDKN1A—ocular cancer	8.07e-06	0.000145	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—CDKN1A—ocular cancer	8e-06	0.000144	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GNAQ—ocular cancer	7.95e-06	0.000143	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—EP300—ocular cancer	7.77e-06	0.00014	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—EP300—ocular cancer	7.77e-06	0.00014	CbGpPWpGaD
Vemurafenib—RAF1—Disease—EP300—ocular cancer	7.68e-06	0.000138	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—EP300—ocular cancer	7.61e-06	0.000137	CbGpPWpGaD
Vemurafenib—BRAF—Disease—HRAS—ocular cancer	7.59e-06	0.000136	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—TGFB1—ocular cancer	7.42e-06	0.000133	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GNA11—ocular cancer	7.24e-06	0.00013	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—MYC—ocular cancer	6.77e-06	0.000122	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—TGFB1—ocular cancer	6.75e-06	0.000121	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GNAQ—ocular cancer	6.73e-06	0.000121	CbGpPWpGaD
Vemurafenib—BRAF—Disease—AKT1—ocular cancer	6.7e-06	0.000121	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—MDM2—ocular cancer	6.7e-06	0.000121	CbGpPWpGaD
Vemurafenib—RAF1—Disease—MYC—ocular cancer	6.69e-06	0.00012	CbGpPWpGaD
Vemurafenib—RAF1—Disease—TGFB1—ocular cancer	6.67e-06	0.00012	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—MYC—ocular cancer	6.63e-06	0.000119	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—TGFB1—ocular cancer	6.61e-06	0.000119	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—EP300—ocular cancer	6.37e-06	0.000115	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—HRAS—ocular cancer	6.23e-06	0.000112	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CDKN1B—ocular cancer	6.12e-06	0.00011	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—TP53—ocular cancer	6.11e-06	0.00011	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—HRAS—ocular cancer	5.84e-06	0.000105	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CCND1—ocular cancer	5.84e-06	0.000105	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—HRAS—ocular cancer	5.69e-06	0.000102	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CDKN1A—ocular cancer	5.65e-06	0.000102	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—EP300—ocular cancer	5.61e-06	0.000101	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GNA11—ocular cancer	5.59e-06	0.0001	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—TP53—ocular cancer	5.56e-06	9.99e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—AKT1—ocular cancer	5.5e-06	9.88e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	5.43e-06	9.77e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—EP300—ocular cancer	5.37e-06	9.66e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—HRAS—ocular cancer	5.32e-06	9.56e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—HRAS—ocular cancer	5.25e-06	9.44e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—HRAS—ocular cancer	5.21e-06	9.36e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GNAQ—ocular cancer	5.2e-06	9.34e-05	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—AKT1—ocular cancer	5.16e-06	9.27e-05	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—AKT1—ocular cancer	5.02e-06	9.03e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—AKT1—ocular cancer	4.69e-06	8.44e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—MYC—ocular cancer	4.68e-06	8.42e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—TGFB1—ocular cancer	4.67e-06	8.4e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—AKT1—ocular cancer	4.64e-06	8.34e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—AKT1—ocular cancer	4.6e-06	8.26e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—AKT1—ocular cancer	3.85e-06	6.92e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—TP53—ocular cancer	3.85e-06	6.91e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—HRAS—ocular cancer	3.68e-06	6.61e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—EP300—ocular cancer	3.46e-06	6.22e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—AKT1—ocular cancer	3.39e-06	6.09e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—AKT1—ocular cancer	3.25e-06	5.84e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—EP300—ocular cancer	2.86e-06	5.13e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—EP300—ocular cancer	2.42e-06	4.35e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—AKT1—ocular cancer	2.09e-06	3.76e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—EP300—ocular cancer	1.87e-06	3.36e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—AKT1—ocular cancer	1.73e-06	3.1e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—AKT1—ocular cancer	1.46e-06	2.63e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—AKT1—ocular cancer	1.13e-06	2.03e-05	CbGpPWpGaD
